Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPA System in Depressed Patients Treated With Amitriptyline or Paroxetine
NCT01049347Phase 3Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Oct 1997
- Primary completion
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amitriptyline, paroxetine in major depressive disorder (MDD), sponsored by Central Institute of Mental Health. Started Oct 1997; status: completed.
02
Drugs
amitriptylineparoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01049347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01049347.